SHENZHEN, CHINA – Media OutReach Newswire – 4 March 2024 – The much-anticipated OnePlus Watch 2, the latest iteration of the OnePlus smartwatch series, is now officially on sale in India, Europe, and North America. Launched at the Mobile World Congress (MWC) on February 26, the OnePlus Watch 2 quickly …
Read More »SETTLEMENT AMIN, AGALPUR TAHASIL, DIST-BOLANGIRARRESTEDBY ODISHA VIGILANCE WHILE ACCEPTING RS.5,000/- BRIBE FOR ISSUANCE OF ROR (LAND PATTA) IN A MUTATION CASE.
Bhubaneswar,4/3/2024 ( Odisha Samachar)- Today i.e. on 04.03.2024, Sri SadanandaSahu, Settlement Amin, AgalpurTahasil, Dist-Bolangir has been apprehended by Odisha Vigilance for demanding and accepting undue advantage (bribe) of Rs.5,000/-(Rupees Five Thousand) from a complainant for processing and issuance of RoR (Land Patta) in his favour in a mutation case registered …
Read More »ICAR-CIFA motivates school students to pursue science as a career
Bhubaneswar,4/3/2024 ( Odisha Samachar)- ICAR-Central Institute of Freshwater Aquaculture, a premier institute for research in freshwater aquaculture observed National Science Day today. The Institute observed an open day where in young school children fromArjunaswardev Nodal High School,KairiPipiliand RadhamohandevUchaBidyapitha,GangapurpatnaDelanga came and explored fishery science. Scientists of the institute took the student …
Read More »Pecan Energies, operator of Deepwater Tano/Cape Three Points (DWT/CTP) block, completes rebranding, committing to unlock prosperity for Ghana and beyond
ACCRA, GHANA – EQS Newswire – 4 March 2024 – Pecan Energies (www.PecanEnergies.com), the operator of the Deepwater Tano/Cape Three Points (DWT/CTP) block offshore Ghana is thrilled to announce the successful completion of its rebranding journey. The company has evolved with a new name, logo, and a revitalized brand identity …
Read More »Focused on positive impact: Ricola becomes a B Corporation
LAUFEN, SWITZERLAND – Newsaktuell – 4 March 2024 – Marking an important milestone on its sustainability journey, Ricola is now a certified B Corporation™. This step reflects Ricola’s long-standing commitment to environmental stewardship and social responsibility, in line with its values as a family-owned enterprise. As B Corporation, Ricola has …
Read More »Berlin Cures’ BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients in randomized placebo-controlled Phase-II-trial now recruited; no issues regarding safety observed. Berlin Cures innovative platform develops novel aptamer-based drugs to neutralize pathogenic functional autoantibodies, targeting …
Read More »Inclusive Education for Visually Impaired Students
SSEPD Department Signs MoU with IIT, BBS Bhubaneswar,4/3/2024 (Odisha Samachar/Rajat Mohapatra)- SSEPD Department has roped in IIT, Bhubaneswar focusing on inclusive and quality education for visually impaired students in the State. An MoU has been signed in this direction between the Department and IIT, Bhubaneswar today which envisages for …
Read More »Heng An Standard Life (Asia) fully supports Hong Kong new Capital Investment Entrant Scheme with ILAS now available for application
HONG KONG SAR – Media OutReach Newswire – 4 March 2024 – Heng An Standard Life (Asia) Limited (“HASL Asia” or “the Company”) welcomes and fully supports Hong Kong new Capital Investment Entrant Scheme (CIES). The company is committed to tying in with government policies to improve Hong Kong’s competitive …
Read More »HPV Affects Us All – Be Protected and Make It #OneLessWorry
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 4 March 2024 – Human papillomavirus (HPV) is the primary cause of cervical cancer. Despite being a preventable disease, cervical cancer ranks as the 4th most frequent cancer among women and the second most frequent cancer among women aged 15 to 44 …
Read More »Berlin Cures’ BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over 50% of patients in randomized placebo-controlled Phase-II-trial now recruited; no issues regarding safety observed. Berlin Cures innovative platform develops novel aptamer-based drugs to neutralize pathogenic functional autoantibodies, targeting …
Read More »